L01EB09 Lazertinib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 1 drug in this drug class.
- 1 prescription (Rx)
Active ingredient: Lazertinib (lazertinib mesylate) – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01EB09 Lazertinib 1 drug
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Lazcluze PM | prescription (Rx) |
Other classes of the same level
- L01EB01 Gefitinib 4 drugs
- L01EB02 Erlotinib 5 drugs
- L01EB03 Afatinib 4 drugs
- L01EB04 Osimertinib 1 drug
- L01EB07 Dacomitinib 1 drug
Other names of the drug class
- German (Switzerland): L01EB09 Lazertinib
- French (Switzerland): L01EB09 Lazertinib
- Italian (Switzerland): L01EB09 Lazertinib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EB09
Ask your doctor or pharmacist for advice.